Work

An objective assessment of the differences between synthetic and digital mammography using AI

Year: 2026
Type: dissertation
Abstract: Background and purpose: Breast cancer is the most common type of cancer among women in Sweden. The mortality can be significantly reduced if the breast cancer is detected at an early stage. Screening programs in Sweden are offered for all woman between 40-74 years, using conventional digital mammography (DM). Digital breast tomosynthesis (DBT) is superior to DM in terms of diagnostic accuracy, but has a higher work- load than DM. From the DBT image volume, a synthetic mammography (SM) image is reconstructed. A potential screening strategy would be to image all women with DBT and let an AI system triage the women depending on their breast cancer risk to be investigated by SM (low-risk women, which is a majority of the women in a screening population), or their DBT images (high-risk women). The SM images could potentially be used as a substitute for DM, to achieve a suitable combination of SM for low-risk women, and DBT for high-risk women. This study aims to investigate whether SM reconstructed from DBT image volumes is equivalent to DM regarding diagnostic accuracy, by using AI cancer detection software. Material and Methods: One hundred women recalled from screening were invited to participate in this preparatory study. The women who accepted to participate underwent imaging using two different modalities, DBT and DM. SM was reconstructed from the DBT volumes. The imaging is performed at Unilabs, Malmö, Sweden, using a clinically used mammography screening device (B.brilliant, Siemens Healthineers, Forchheim, Germany). An AI system, Transpara (Screenpoint Medical, Nijmegen, NL) was used to analyze the images. For this study to compare SM to DM, the AI-system needed to explicitly process only SM. To accomplish this, the SM images were presented in the same format as DM images, by changing the DICOM-information and the image background. The change of the image backgrounds was necessary as DBT and SM images were cropped, unlike DM which used a set field of view. The AI-system provided a risk score that represents the level of cancer suspicion. The AI risk scores of the SM and DM with the malignant cases was compared using a statistical test to test the null hypothesis that there is no significant difference between the modalities. Further analysis of all 100 cases was done using ROC analysis to evaluate diagnostic accuracy. Results: Among the malignant cases, the SM yielded consistently higher risk score than DM. A Wilcoxon signed-rank test confirmed a statistically significant paired difference between modalities (p=3.597×10⁻⁶). From the ROC analysis of the 100 cases, the resulting area under the curve, AUC, for DM was 0.843 compared to the AUC for SM which was 0.753. Based on DeLong’s test the difference in AUC indicated that there was no significant difference between the two modalities (p=0.071). Conclusion: These results indicate that SM provides AI risk scores comparable to, or higher, than DM for malignant cases. The ROC curve for SM showed a tendency toward higher false-positive rates, suggesting increased sensitivity. If further studies confirm that the diagnostic accuracy between the modalities show no significant difference, then these findings of SM are supporting its suitability as a potential substitute for DM images in future screening programs.
Institution: Lund University
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7203846148
Cites: 27
Cited by:
Related to: 10